In Vivo Selection of Phage for the Optical Imaging of PC-3 Human Prostate Carcinoma in Mice
Overview
Affiliations
There is an increasing medical need to detect and spatially localize early and aggressive forms of prostate cancer. Affinity ligands derived from bacteriophage (phage) library screens can be developed to molecularly target prostate cancer with fluorochromes for optical imaging. Toward this goal, we used in vivo phage display and a newly described micropanning assay to select for phage that extravasate and bind human PC-3 prostate carcinoma xenografts in severe combined immune deficiency mice. One resulting phage clone (G1) displaying the peptide sequence IAGLATPGWSHWLAL was fluorescently labeled with the near-infrared fluorophore AlexaFluor 680 and was evaluated both in vitro and in vivo for its ability to bind and target PC-3 prostate carcinomas. The fluorescently labeled phage clone (G1) had a tumor-to-muscle ratio of approximately 30 in experiments. In addition, prostate tumors (PC-3) were readily detectable by optical-imaging methods. These results show proof of principle that disease-specific library-derived fluorescent probes can be rapidly developed for use in the early detection of cancers by optical means.
Improving Pharmacokinetics of Peptides Using Phage Display.
Asar M, Newton-Northup J, Soendergaard M Viruses. 2024; 16(4).
PMID: 38675913 PMC: 11055145. DOI: 10.3390/v16040570.
Phage Display's Prospects for Early Diagnosis of Prostate Cancer.
Petrenko V Viruses. 2024; 16(2).
PMID: 38400052 PMC: 10892688. DOI: 10.3390/v16020277.
Sloth A, Bakhshinejad B, Stavnsbjerg C, Rossing M, Kjaer A Int J Mol Sci. 2023; 24(6).
PMID: 36982469 PMC: 10049078. DOI: 10.3390/ijms24065396.
Selection of Cancer Stem Cell-Targeting Agents Using Bacteriophage Display.
Prater A, Deutscher S Methods Mol Biol. 2022; 2394:787-810.
PMID: 35094358 DOI: 10.1007/978-1-0716-1811-0_41.
Circulation of Fluorescently Labelled Phage in a Murine Model.
Kazmierczak Z, Majewska J, Milczarek M, Owczarek B, Dabrowska K Viruses. 2021; 13(2).
PMID: 33672895 PMC: 7917791. DOI: 10.3390/v13020297.